The track-only hypercar from red Bull Advanced Technologies has officially entered its final assembly phase, meaning the first customer cars are being physically built.

🔧 What’s happening right now?

Recent updates from multiple industry reports confirm:

Final assembly of the first RB17 has begun in the UK

Early track testing is expected to start “within weeks”

The car is transitioning from prototype to production specification

👉 This marks the final stage before customer deliveries begin.

🚗 Delivery timeline (important)

Deliveries expected: from spring 2027 onward

Production will continue into 2028

Only 50 units are being built

Each car is already allocated to buyers

So yes—when reports say “close to production,” it’s already beyond concept stage and essentially in early production build phase.

⚙️ What makes the RB17 special?

Key performance highlights:

~1,200 hp hybrid powertrain

Extremely lightweight (~900 kg range)

Track-only hypercar (not road legal)

Designed by legendary F1 designer Adrian Newey

Built using Formula 1-level aerodynamics and carbon-fiber construction

It is widely described as a machine capable of matching or even beating F1 lap times on certain circuits.

💡 Why this hypercar is getting so much attention

Unlike typical hypercars:

It is not just a collector’s road car

It is a fully track-focused performance machine

Owners are expected to receive driving support and track training from red Bull

It is essentially an “F1 car for customers”

🧭 Bottom line

The RB17 is no longer a concept or showpiece—it is:

✔ In final assembly

✔ Entering real-world testing

✔ Fully sold out

✔ Heading toward deliveries starting around 2027

So the phrase “close to production” is accurate—but in reality, it is already inside the production pipeline.

 

Disclaimer:

The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy or position of any agency, organization, employer, or company. All information provided is for general informational purposes only. While every effort has been made to ensure accuracy, we make no representations or warranties of any kind, express or implied, about the completeness, reliability, or suitability of the information contained herein. Readers are advised to verify facts and seek professional advice where necessary. Any reliance placed on such information is strictly at the reader’s own risk.

Find out more: